Clinical Trial Update: Safety and Efficacy Study of Avotermin (Juvista) in Female Subjects [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating Avotermin (Juvista) for scar improvement and wound healing in female subjects has completed, with safety and efficacy data reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cicatrix

Drugs mentioned

• Juvista (avotermin)

Snippet

Sponsor: Renovo | Conditions: Cicatrix, Wound Healing | Phase 1, Phase 2 | Status: COMPLETED